Mihara Koichiro, Ramachandran Rithwik, Saifeddine Mahmoud, Hansen Kristina K, Renaux Bernard, Polley Danny, Gibson Stacy, Vanderboor Christina, Hollenberg Morley D
Inflammation Research Network-Snyder Institute for Chronic Disease, Department of Physiology and Pharmacology (K.M., R.R., M.S., K.K.H., B.R., D.P., S.G., M.D.H.), and Department of Medicine (M.D.H.), University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada; and Department of Physiology and Pharmacology, Western University, London, Ontario, Canada (C.V., R.R.).
Inflammation Research Network-Snyder Institute for Chronic Disease, Department of Physiology and Pharmacology (K.M., R.R., M.S., K.K.H., B.R., D.P., S.G., M.D.H.), and Department of Medicine (M.D.H.), University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada; and Department of Physiology and Pharmacology, Western University, London, Ontario, Canada (C.V., R.R.)
Mol Pharmacol. 2016 May;89(5):606-14. doi: 10.1124/mol.115.102723. Epub 2016 Mar 8.
Thrombin is known to signal to cells by cleaving/activating a G-protein-coupled family of proteinase-activated receptors (PARs). The signaling mechanism involves the proteolytic unmasking of an N-terminal receptor sequence that acts as a tethered receptor-activating ligand. To date, the recognized targets of thrombin cleavage and activation for signaling are PAR1 and PAR4, in which thrombin cleaves at a conserved target arginine to reveal a tethered ligand. PAR2, which like PAR1 is also cleaved at an N-terminal arginine to unmask its tethered ligand, is generally regarded as a target for trypsin but not for thrombin signaling. We now show that thrombin, at concentrations that can be achieved at sites of acute injury or in a tumor microenvironment, can directly activate PAR2 vasorelaxation and signaling, stimulating calcium and mitogen-activated protein kinase responses along with triggeringβ-arrestin recruitment. Thus, PAR2 can be added alongside PAR1 and PAR4 to the targets, whereby thrombin can affect tissue function.
已知凝血酶通过切割/激活一类G蛋白偶联的蛋白酶激活受体(PARs)向细胞发出信号。信号传导机制涉及蛋白水解作用使一个N端受体序列暴露,该序列充当拴系式受体激活配体。迄今为止,凝血酶切割和激活用于信号传导的公认靶点是PAR1和PAR4,其中凝血酶在保守的靶精氨酸处切割以暴露拴系配体。PAR2与PAR1一样,也在N端精氨酸处被切割以暴露其拴系配体,通常被认为是胰蛋白酶的靶点而非凝血酶信号传导的靶点。我们现在表明,在急性损伤部位或肿瘤微环境中能够达到的浓度下,凝血酶可以直接激活PAR2介导的血管舒张和信号传导,刺激钙和丝裂原活化蛋白激酶反应,并触发β-抑制蛋白募集。因此,PAR2可以与PAR1和PAR4一起添加到凝血酶可影响组织功能的靶点中。